Albutein: payments to doctors
Payments that named Albutein as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $460K
- Providers
- 96
- Transactions
- 305
- Average per transaction
- $1,507
The per-transaction average — $1,507 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 96 providers the average total is $4,788, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Grifols Shared Services North America, Inc. | $304,928 | 66.3% |
| Grifols Biologicals LLC | $107,439 | 23.4% |
| Grifols, S.A. | $33,896 | 7.4% |
| Grifols Therapeutics LLC | $11,454 | 2.5% |
| Grifols USA, LLC | $1,919 | 0.4% |